Both the PDA/BCP and BCP groups had poor positive EphB4/EphrinB2 molecules expression, while the EPO/BCP and EPO/pDA/BCP groups had strong positive expression. The gene discussed is EPHB4; the disease is Patent ductus arteriosus.